<?xml version="1.0" encoding="UTF-8"?>
<Progress_Report_Checklist
><Grant_Information
><RFA_Number
>06-01</RFA_Number
><Grant_Number
>RS1-00466-1</Grant_Number
><Reporting_Period_Start
>10/1/2008</Reporting_Period_Start
><Reporting_Period_End
>9/30/2009</Reporting_Period_End
><Institution_Name
>Burnham Institute for Medical Research</Institution_Name
><Primary_Investigator
><Prefix
/><First_Name
>Alexey</First_Name
><Middle_Name
/><Last_Name
>Terskikh</Last_Name
><Suffix
/><Degree
/><Institution
/><Title
/><Department
/><Email
/><Telephone_Number
/><Extension
/><Fax_Number
/></Primary_Investigator
></Grant_Information
><Reviewer_Information
><Grants_Manager
><Prefix
/><First_Name
/><Middle_Name
/><Last_Name
/><Suffix
/><Degree
/><Institution
/><Title
/><Department
/><Email
>alewis</Email
><Telephone_Number
/><Extension
/><Fax_Number
/></Grants_Manager
><Science_Officer
><Prefix
/><First_Name
/><Middle_Name
/><Last_Name
/><Suffix
/><Degree
/><Institution
/><Title
/><Department
/><Email
>lcollins</Email
><Telephone_Number
/><Extension
/><Fax_Number
/></Science_Officer
></Reviewer_Information
><Reviews
><Budget_Review
><IsRequired
/><Grant_Manager_Notes
>Grantee reports anticipated expenditures of all funds allocated for Year 2.  No carry forward.  Will confirm with financial report.  No budget justification detail.</Grant_Manager_Notes
><Science_Officer_Notes
/><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></Budget_Review
><California_Supplier_Review
><IsRequired
/><Grant_Manager_Notes
>Grantee reports 14.3% purchases from CA suppliers due to specific supply needs for the requirements of this research project.</Grant_Manager_Notes
><Science_Officer_Notes
/><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
/><IsComplete
/></California_Supplier_Review
><Key_Personnel_Review
><IsRequired
/><Grant_Manager_Notes
/><Science_Officer_Notes
>pending PI response 24Mar10</Science_Officer_Notes
><Grant_Manager_Approval
/><Science_Officer_Approval
>0</Science_Officer_Approval
><IsComplete
/></Key_Personnel_Review
><IACUC_Assurances_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
>Note murine studies have been performed, but renewed IACUC not yet received.  Awaiting PI response 24Mar10.  PI and GMO have been reminded multiple times by SO and GMO as of 26Jul10, still no IACUC received, file returned.</Science_Officer_Notes
><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>0</Science_Officer_Approval
><IsComplete
/></IACUC_Assurances_Review
><IRB_Assurances_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
>joint IRB SCRO remewal received, appropriately cites CIRM award.</Science_Officer_Notes
><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></IRB_Assurances_Review
><SCRO_Assurances_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
>SCRO approval 2009-B00023SCRO from 10/19/09 - 10/28/10.  No lapse in coverage from previously provided approval.</Grant_Manager_Notes
><Science_Officer_Notes
/><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></SCRO_Assurances_Review
><Publication_Reporting_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
>no publications this reporting period.  a manuscript is under revision for potential publication this year.  CIRM is cited in the acknowledgements.</Science_Officer_Notes
><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></Publication_Reporting_Review
><Invention_Licensing_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
>invention disclosure noted in progress report</Science_Officer_Notes
><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></Invention_Licensing_Review
><PI_Effort_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
>OS requested 24Mar10</Science_Officer_Notes
><Grant_Manager_Approval
/><Science_Officer_Approval
>0</Science_Officer_Approval
><IsComplete
/><Total_Current_Effort
>0</Total_Current_Effort
><CIRM_Award_Effort
>0</CIRM_Award_Effort
></PI_Effort_Review
></Reviews
><Award_Conditions
><Conditions_Exist
>0</Conditions_Exist
><Conditions_Met
><Conditions_Met
/><Grants_Manager_Notes
/><Grants_Manager_Approval
>0</Grants_Manager_Approval
><Science_Officer_Notes
/><Science_Officer_Approval
>0</Science_Officer_Approval
></Conditions_Met
><New_Conditions
><New_Conditions
>0</New_Conditions
><Grants_Manager_Notes
/><Grants_Manager_Approval
>0</Grants_Manager_Approval
><Science_Officer_Notes
/><Science_Officer_Approval
>0</Science_Officer_Approval
></New_Conditions
></Award_Conditions
><Prior_Approval
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
/><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>0</Science_Officer_Approval
><IsComplete
/></Prior_Approval
><Evaluation
><Overall_Rating
>Adequate</Overall_Rating
><Translational_Status
>No substantial change, incremental, or N/A</Translational_Status
><Executive_Summary
>Good progress, consistent use of human cells.  Unfortunately, for the most part grantee has been scooped on hNCSC isolation early in the award. The real fruit of the work will be the further study of the isolated cells which can now be pursued.  The PI appears to have isolated a different NCSC population that Studer’s HNK-1/p75 population as PIs population appears homogenenously multipotent while Studer’s appears to be a mixed population.  Putative hNCSC were isolated from neural epithelium via their migratory behavior.  Gene expression profiling reveals differences between these cells and parental clusters, with NCSC markers having increased expression.   Notably, these cells retain their developmental potential after several weeks in culture.  After microinjection of the cells into aganglionic murine gut segments, differentiation into neurons was observed, although functional coupling has yet to be determined.  It would be satisfying to see this type of data to confirm therapeutic feasibility of this cell type.  Award to close out.  It appears full award has been spent.&#xD;</Executive_Summary
></Evaluation
><Strategic_Outcome
><Five_Year_Goal_1
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_1
><Five_Year_Goal_2
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_2
><Five_Year_Goal_3
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_3
><Five_Year_Goal_4
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_4
><Five_Year_Goal_5
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_5
><Five_Year_Goal_6
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_6
><Five_Year_Goal_8
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_8
><Ten_Year_Goal_1
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_1
><Ten_Year_Goal_2
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_2
><Ten_Year_Goal_5
><IsApplicable
>1</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
>working towards this goal.  cells can be made but DMA not yet demonstrated.</Outcomes
><Impact_Factor
>1</Impact_Factor
></Ten_Year_Goal_5
><Ten_Year_Goal_7
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_7
><Ten_Year_Goal_8
><IsApplicable
>1</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
>has found a method to both make and expand NCSC (previously described as short lived).  this should enable further study of the cells and determination of their therapeutic feasibility.</Outcomes
><Impact_Factor
>2</Impact_Factor
></Ten_Year_Goal_8
><Ten_Year_Goal_9a
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_9a
><Ten_Year_Goal_9b
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_9b
><Ten_Year_Goal_10
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_10
></Strategic_Outcome
><IsComplete
/></Progress_Report_Checklist
>